Chemical Structure (Divalproex 01)
Divalproex Sodium Tablet, Delayed Release
Product Images NDC 0832-7124
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 0832-7124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Divalproex 02)
This is a table showing percentages and some codes for studies 1 and 2, along with the YMRS and MRS rating scales. Specific details about the studies or what the codes represent are not available.*
Figure 2 (Divalproex 03)
The text describes a chart showing the % Reduction in CPS (likely meaning "cycles per second") Rate for patients taking either Divalproex sodium or Placebo. The chart shows a range of percentages from -50% to 100% reduction, with the majority of patients in the 0-50% range. The chart also shows the percentage of patients who saw improvement, no change, or worsening in their condition.*
Figure 3 (Divalproex 04)
This document appears to be a chart displaying the percentage reduction in CPS (central pain syndrome) rate categorized by high and low dose. It also indicates the percentage of patients and the level of improvement or worsening.*
Figure 4 (Divalproex 05)
This appears to be a list of names related to some medical study or research. More context is required to provide a useful description.*
Principal Display Panel (125 mg Tablet Bottle Label)
Diettgey is a delayed-release tablet that contains 125mg of valproic acid activity. These tablets are children resistant, and should be stored at a temperature between 20-25°C. Each tablet contains divaproex sodium equivalent to valproic acid. It is recommended to swallow tablets whole and not to chew or crush them. The package is manufactured by Upsher-smith laboratories, LLC in Maple Grove, MN55369.*
Principal Display Panel (250 mg Tablet Bottle Label)
DAETTGEY @ Delayed-Release Tablets, USP 250 mg is a drug used for Valproic Acid Activity, containing 100 tablets which are available only on prescription. Each tablet has Divaproex Sodium equivalent to valproic acid of 250mg. The usual dosage is specified on the package which is a child-resistant container and should be stored in a cool dry place. These tablets should not be crushed and should be kept out of reach of children. Manufactured by PSHER-SMITH LABORATORIES, LLC in Minnesota. Unfortunately, no additional information was displayed.*
Principal Display Panel (500 mg Tablet Bottle Label)
This is a description for medication tablets containing 500mg of delayed-release valproic acid, used for the treatment of seizures and bipolar disorder. The package contains 100 tablets and should be stored at controlled room temperature. The tablets should be swallowed whole and stored in a child-resistant container. The medication should only be dispensed with a prescription and the package insert should be consulted for full prescribing information. The manufacturer is Upsher-Smith Laboratories.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
